Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
0(0%)
Results Posted
29%(2 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_3
5
50%
Ph phase_4
1
10%
Ph phase_1
3
30%

Phase Distribution

3

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
3(33.3%)
Phase 3Large-scale testing
5(55.6%)
Phase 4Post-market surveillance
1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(7)
Terminated(2)
Other(1)

Detailed Status

Completed7
Withdrawn1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (33.3%)
Phase 35 (55.6%)
Phase 41 (11.1%)

Trials by Status

withdrawn110%
terminated110%
unknown110%
completed770%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10